Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug combinations
Pharma
Pfizer details survival win in bid for broad prostate cancer nod
Pfizer hopes a unique life-extension benefit for Talzenna can serve to further expand the drug's already broadest-in-class prostate cancer label.
Angus Liu
Feb 13, 2025 10:00am
Pfizer's blockbuster ADC Adcetris nabs FDA nod in LBCL
Feb 12, 2025 3:06pm
Pfizer angles Braftovi combo for full FDA approval
Feb 3, 2025 9:54am
BMS, Pfizer tout new standards in colorectal cancer subtypes
Jan 25, 2025 3:00pm
ASH: GSK details Blenrep's survival win against J&J's Darzalex
Dec 9, 2024 1:30pm
Jazz's almost-withdrawn lung cancer drug shows life
Oct 15, 2024 10:15am
